Skip to main content

pharma courses

Idorsia receives Japanese PMDA approval of PIVLAZ (clazosentan sodium)150 mg

Idorsia Ltd and Idorsia Pharmaceuticals Japan today announce that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved PIVLAZ™ (clazosentan sodium) 150 mg, a selective endothelin A (ETA) receptor antagonist, for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage (aSAH). The PMDA approval of PIVLAZ is based on a dedicated Japanese Phase 3 program.

Apprentice.io Raises USD100 Million to Adapt Pharma Supply Chains to the Omicron Variant

Apprentice.io has raised USD 100 million in Series C funding led by new investor Alkeon Capital Management, with repeat participation from Silverton Partners, Insight Partners, Pacific Western Bank, and new investment by Colorcon Ventures. The company will use the capital to help pharma manufacturers harden their supply chains to keep making patient-critical drugs and adapt vaccines to meet the evolving strains of COVID-19.

VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis

Vifor Fresenius Medical Care Renal Pharma announced that the European Commission has approved Tavneos in combination with a rituximab or cyclophosphamide regimen for the treatment of adult patients with severe, active granulomatosis polyangiitis (GPA) or microscopic polyangiitis (MPA), the two main forms of ANCA-associated vasculitis. The approval is consistent with expectations and overall follows the U.S. Food and Drug Administration (FDA) approval of Tavneos in October 2021 for the same indication.

Recruitment for Pharmacists (06 posts) at District Integrated Health and Family Welfare Society

The National Health Mission aims to provide services on contract basis to medical officers, cold chain technicians, drug manufacturers, staff nurses and accountants under various programs at Zilla Parishad, Aurangabad level. Accordingly, the aspiring candidates for the following services should submit their application for the following services by post or in person in the form mentioned below, excluding holidays during the office hours from the date of advertisement publication. Late applications received (directly / by post) will not be considered.

Recruitment for Pharmacists (06 posts) at Indian Red Cross Society

The following human resources are urgently needed for the control of Corona epidemic.  Interested candidates will be selected through walk-in-interview.

Post : Pharmacist

No of Posts : 6

Qualification : D.Pharm, B.Pharm

Salary : Rs 16,500/- pm

Opportunity for Pharma and lifesciences Scientist at THSTI, Ministry of Science and Technology

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt, of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

Pharmacy Graduate Job at Indira Gandhi Institute of Medical Sciences

IGIMS was established on 19th November 1983, as an autonomous organisation on the pattern of All India Institute of Medical Sciences, New Delhi. The objective was to provide super specialty medical facilities in Bihar. On 27th January 1983 Cabinet approved the completion of this massive project in 4 phases within a span of six (6) years. According to the decision of State Government, 130.20 Acres of land was transferred to IGIMS.

An online interview of eligible Indian Citizen for appointment to above post has been fixed on.

Ph.D, M.Pharm, M.Sc Job under Department of Biotechnology, NIPER

NIPER Ahmedabad was initiated with three specializations Biotechnology, Natural Products and Pharmaceutics and over the period of time three more specialisations Pharmaceutical Analysis, Medicinal Chemistry and Pharmacology and Toxicology were added in 2010. Subsequently in 2011, to cater the needs of Medical device industry in India, another feather was added to the cap of NIPER Ahmedabad in the form of specialisation in Medical Devices.

Pharma, Life Sciences recruitment at University of Hyderabad | Salary upto Rs. 60,000 pm

The University of Hyderabad one of the major institutions of higher education in India is largely devoted to postgraduate studies and is widely known for its excellence in research and for its distinguished faculty. Founded in 1974 with Prof. Gurbaksh Singh as its first Vice Chancellor, UoH - also known as Hyderabad Central University or HCU- has emerged as a leading centre of teaching and research.

Job for Assistant Professor at Siddhi Vinayak Group of Institutions

Shri Vinayak Education Society managing Siddhi Vinayak Group of Institutions was formed by a group of Educationists for the promotion of good Colleges, Institutions and Schools in various parts of Delhi and neighbor states. The Promoters of the Engineering college and other colleges are running one of the biggest Centrally Air Conditioned School and B.Ed. College at Delhi for the last 14 years having vast knowledge in providing best ever Educational atmosphere & facilities.

Job for Assistant Professor at GR Medical College Hospital & Research Center

G.R. Medical College, Hospital & Research Centre stands apart amongst all the medical colleges in Mangalore because of its unique topography, connectivity and persistent leadership in medical training and health care for common man. The College is a leading provider of professional Medical Education in the country, integrating highest standards of academic excellence with ethics and spirituality and providing Health Care to the Society.The Institution not only provide students with quality education but also groom them to face life with confidence.

Opportunity for Ph.D, M.Pharm, M.Sc as Associate Scientist at Johnson and Johnson

Janssen India, the pharmaceutical division of Johnson & Johnson India, is dedicated to addressing and solving some of the most important unmet medical needs of our time in India, in oncology, immunology, neuroscience and analgesia, dermatology, infectious diseases and metabolic diseases. Driven by a strong dedication to the health and well-being of patients, Janssen India brings innovative products, services and solutions to people throughout the world.

Vacancy for Professor, Assistant Professor at Shree Dhanvantary Pharmacy College

Shree Dhanvantary Pharmacy College is pioneer educational institute and research centre in south Gujarat region. The institute is located in the sprawling campus of 8.32 acres, in Kim. Shree Dhanvantary Pharmacy College has built its own credentials.

Clinical Research Associate require at Teva Pharmaceutical

Teva is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day. We offer a uniquely diverse portfolio of products and solutions for patients and we've built a promising pipeline centered around our core therapeutic areas.

Regulatory Affairs & Pharmacovigilance Manager Job at Ferring India

Ferring is a research-driven, specialty biopharmaceutical group committed to helping people build healthy families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology.

Post : Manager - Regulatory Affairs & Pharmacovigilance

QC, AMV Jobs at IPCA Laboratories Ltd

Ipca has been partnering healthcare globally in over 110 countries and in markets as diverse as Africa, Asia, Australia, Europe and the US. Ipca is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments.

Oral penicillin, not injectable, advised for people with high-risk rheumatic heart disease

A growing body of evidence indicates that some people thought to have an allergic response to injectable penicillin, the standard treatment for rheumatic heart disease, may instead be experiencing a cardiac reaction to the medicine, according to a new American Heart Association presidential advisory published today in Journal of the American Heart Association.

Health Canada authorizes PAXLOVIDTM for patients with mild to moderate COVID-19 at high risk of developing serious disease

Health Canada has authorized the combination of two antiviral drugs, nirmatrelvir and ritonavir (brand name PAXLOVIDTM), to treat adults with mild to moderate COVID-19 who are at high risk of progressing to serious disease, including hospitalization or death. The active ingredient nirmatrelvir in PAXLOVIDTM works by stopping the virus from replicating.

Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant

Pfizer Inc shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), is maintained against the SARS-CoV-2 variant Omicron. Taken together, these in vitro studies suggest that PAXLOVID has the potential to maintain plasma concentrations many-fold times higher than the amount required to prevent Omicron from replicating in cells.

BiologyWorks k(now) COVID-19 Clinical Trial matches 99.1 percent accuracy to RT-PCR Tests

The independent clinical trial, conducted by Locus Medicus in Athens, Greece, prospectively tested 330 patients with symptomatic and asymptomatic cases of COVID-19. For the study, staff at the clinical laboratory collected two bilateral anterior nasal swabs from each patient. Immediately after collection, one swab was tested in the lab’s standard of care CE-Mark RT-PCR test and the other swab was tested by BiologyWorks k(now). Results from the BiologyWorks k(now) molecular test were 99.1% in overall percent agreement with the results of the RT-PCR lab tests.

Subscribe to